A stronger margin does not fund the whole reset. Direct sales and Greater China remain weak, while dividends and Pace require cash before the full savings arrive. Our three routes support a rounded $25 central value. At $32.78, the shares price in more recovery than our cash assumptions justify. High uncertainty requires a wider entry cushion.
Analyst scenarios, not company guidance; USD per share
| Measure | Value |
|---|---|
| Bear30% | 16.00 |
| Base50% | 25.00 |
| Bull20% | 40.00 |
| Weighted | 25.30 |
| Reference | 32.78 |
| Scenario | Probability | 12-month value | vs $32.78 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 30% | $16.00 | −51% | Demand and cash recovery remain weak | About$0.90EPS×18,rounded$16 |
| Base | 50% | $25.00 | −24% | Moderate operating repair with cash constraints | Judgment within$20.03cash,$24.50enterprise,$27.50earningsroutes |
| Bull | 20% | $40.00 | +22% | Direct / China recovery and savings convert | Analyst$2sustainableEPS×20 |
Computed expected value:30%×$16+50%×$25+20%×$40=$25.30. Scenario endpoints are neither floors nor ceilings. | |||||
| Signpost | Now (Q1 FY2027) | Green if | Red if | Next check |
|---|---|---|---|---|
| Direct sales | −8% reported | Better than −5% | Below −10% | Q2 ending Nov 30, 2026 |
| Greater China | −22% reported | Better than −15% | Below −25% | Q2 ending Nov 30, 2026 |
| Gross margin | 42.8% | At / above 43% with healthy sales | Below 42% | Q2 ending Nov 30, 2026 |
| FY27 adjusted EPS | $1.15–$1.35 | Midpoint at / above $1.35 | Low end below $1.15 | Next FY27 guide update |
| Cash coverage | FY26 FCF / dividends 0.91× | Above 1× | Below 0.8× | FY27 ending May 31, 2027 |
| Pace FY27 charges | About $300M expected | Within plan with measurable savings | Higher cost without better benefits | FY27 ending May 31, 2027 |
| Valuation | $32.78reference | Near $20 if thesis intact | Fundamentals invalidate base case | Each filing after Oct 1, 2026 |
Analyst decision thresholds established October 1,2026. Future release dates are not assumed; compare consistent definitions.
NIKE is getting cheaper because the recovery keeps demanding more time and cash. The useful question is whether the next stage of the reset can produce enough earnings to justify the price investors still pay. Our answer is cautious: SELL, conviction 3 out of 5, with high uncertainty and a rounded $25 central value. This is a valuation judgment about the ordinary shares, not a prediction that the brand stops mattering. The bull case remains credible, but the saved $32.78 post-release reference already charges investors for meaningful improvement.
The source-bound market snapshot separates the $35.15 completed-session quote from the $32.78 extended-hours observation used in this packet. Their ratio gives a decline of about 6.7% since the print. The daily chart uses completed daily closes; it does not pretend that the later observation was a regular-session closing price. Both observations are dated October 1, 2026. Subsequent trading can change the entry decision, and every valuation multiple here should be recomputed against a later price before relying on it.
The stock has fallen a long way from its saved 52-week high, but a discount to a past quotation is not the same as a discount to future cash. Fiscal 2027 adjusted EPS guidance puts the current reference at more than twenty-six times the midpoint. That multiple can work if the brand reaccelerates, margins improve and restructuring benefits reach shareholders. It becomes harder to defend if direct sales keep contracting and the new operating model first consumes the cash that investors expected to receive.
The provider market capitalization accompanies the regular-session quote. For our enterprise-value calculation we instead multiply the same $32.78 valuation reference by the latest diluted weighted-average share proxy, then subtract net financial cash. That produces an internally consistent illustration, while acknowledging that weighted-average shares are not an exact point-in-time share register. The appendix retains the source observations and the distinction. We do not combine a later share price with an earlier capitalization and describe the resulting ratio as precise.
| Date | Close |
|---|---|
| 2025-07-01 | $73.41 |
| 2025-07-31 | $74.69 |
| 2025-08-29 | $77.37 |
| 2025-09-30 | $69.73 |
| 2025-10-29 | $65.35 |
| 2025-11-28 | $64.63 |
| 2025-12-30 | $61.19 |
| 2026-01-30 | $61.81 |
| 2026-03-03 | $59.39 |
| 2026-04-01 | $44.63 |
| 2026-05-01 | $44.40 |
| 2026-06-02 | $43.73 |
| 2026-07-02 | $44.09 |
| 2026-08-03 | $42.64 |
| 2026-09-01 | $38.12 |
| 2026-10-01 | $35.15 |
| Period | Close-to-close reaction |
|---|---|
| Q1 FY2025 | −6.77 |
| Q2 FY2025 | −0.21 |
| Q3 FY2025 | −5.46 |
| Q4 FY2025 | 15.19 |
| Q1 FY2026 | 6.41 |
| Q2 FY2026 | −10.54 |
| Q3 FY2026 | −15.51 |
| Q4 FY2026 | 4.90 |
The October 1 release covers the first quarter of fiscal 2027, ended August 31, 2026. The income statement places the current quarter first and the August 2025 comparison second. Revenue was $11.213 billion against $11.720 billion a year earlier. Reported sales declined 4%, and currency-neutral sales declined 5%. Gross margin improved to 42.8% from 42.2%, primarily because warehousing and logistics costs were lower. Improvement in the rate did not prevent gross profit dollars from falling, because there was less revenue to apply that rate to.
Demand creation expense increased to $1.252 billion, while operating overhead fell to $2.658 billion. Together they produced $3.910 billion of selling and administrative expense. Marketing investment therefore rose while the administrative cost base contracted. That combination is more constructive than indiscriminate cuts, but the distinction matters: overhead savings support current profit, whereas demand creation still has to earn its return through future customer purchases. Investors should monitor both the margin and the direction of sales rather than treating a lower expense bill as sufficient evidence of a turnaround.
Net income was $712 million and diluted EPS was $0.48. The saved provider consensus showed $0.4365 of EPS and $11.32044 billion of revenue, so the two headline comparisons point in different directions. Those estimates are a dated provider observation rather than company guidance, and their contributor set can change. A modest earnings beat does not settle the broader question raised by the outlook. The more consequential disclosure is that management expects fiscal 2027 revenue to decline at a high-single-digit rate and adjusted EPS of $1.15 to $1.35.
The adjusted EPS outlook excludes approximately $0.15 of fiscal 2027 restructuring expense associated with Pace. Subtracting that estimate gives a simple $1.00 to $1.20 illustrative GAAP bridge, subject to the accuracy and scope of management's estimates. We do not present the adjusted range as unqualified GAAP earnings. The prior fourth quarter also contained a large tariff-recovery benefit; our earlier Nike episode addressed that comparison. This packet instead tests the current sales, cash and restructuring economics without recycling that prior headline.
| Measure | Q1 FY27 | Q1 FY26 | Context |
|---|---|---|---|
| Revenue | $11,213M | $11,720M | −4% reported;−5% currency-neutral |
| Gross profit | $4,798M | $4,943M | Margin 42.8% versus 42.2% |
| Demand creation | $1,252M | $1,188M | Marketing increased |
| Operating overhead | $2,658M | $2,828M | Overhead declined |
| SG&A | $3,910M | $4,016M | Expense ratio 34.9% |
| Operating profit, computed | $888M | $927M | Before interest and other income |
| Pretax income | $921M | $922M | Operating/nonoperating mix differs |
| Net income | $712M | $727M | Higher tax burden |
| Diluted EPS | $0.48 | $0.49 | Current share proxy 1,484.2M |
| Period | Revenue |
|---|---|
| Q1 FY2025 | 11,589.00 |
| Q2 FY2025 | 12,354.00 |
| Q3 FY2025 | 11,269.00 |
| Q4 FY2025 | 11,097.00 |
| Q1 FY2026 | 11,720.00 |
| Q2 FY2026 | 12,427.00 |
| Q3 FY2026 | 11,279.00 |
| Q4 FY2026 | 10,972.00 |
| Q1 FY2027 | 11,213.00 |
| Period | Gross profit | Operating profit |
|---|---|---|
| Q1 FY26 | 4,943.00 | 927.00 |
| Q1 FY27 | 4,798.00 | 888.00 |
North America remains the clearest support for the recovery thesis. Revenue increased to $5.127 billion from $5.020 billion, and regional EBIT increased to $1.170 billion from $1.134 billion. Those results show that parts of the product and wholesale strategy are working. They do not mean the improvement is geographically complete. Greater China revenue fell to $1.180 billion from $1.512 billion, a 22% reported decline and a 26% currency-neutral decline. Its EBIT fell to $248 million from $377 million. The difference between these regions is more useful than an average that hides both.
EMEA revenue declined to $3.176 billion, with EBIT of $728 million. Asia Pacific and Latin America revenue was $1.463 billion, with EBIT of $324 million. These regional profit figures are segment measures and must be read alongside the global brand and corporate costs retained in the consolidated reconciliation. Adding only the profitable geographic rows would overstate group earning power. The packet displays the full source rows and identifies the reconciliation instead of treating geographic EBIT margins as the margin available to every shareholder.
The channel mix is also uneven. NIKE Brand wholesale sales were $6.804 billion, down 1%, while NIKE Direct sales were $4.142 billion, down 8% reported and 9% on a currency-neutral basis. Brand Digital sales declined 13% and owned-store sales declined 5%. Wholesale stabilization helps, but the direct channel carries an important consumer signal. We would be more comfortable underwriting an earnings recovery when digital and store trends improve together, rather than relying on partner inventory and distribution alone.
Product categories tell a similar story. NIKE Brand footwear revenue was $6.951 billion, apparel was $3.384 billion and equipment was $611 million. Apparel improved while footwear and equipment declined. Converse revenue fell to $263 million, down 28%. Management is repositioning Sportswear, Jordan and Greater China while extending the Sport Offense. Those are material operating choices, not separate pools of value that can simply be added to the stock price. The next test is whether better product execution changes the sales trajectory without sacrificing the gross-margin improvement already achieved.
| Measure | Value |
|---|---|
| North America | 5,127.00 |
| EMEA | 3,176.00 |
| Greater China | 1,180.00 |
| APLA | 1,463.00 |
| Period | Q1 FY26 | Q1 FY27 |
|---|---|---|
| North America | 1,134.00 | 1,170.00 |
| EMEA | 735.00 | 728.00 |
| Greater China | 377.00 | 248.00 |
| APLA | 350.00 | 324.00 |
| Period | Q1 FY26 | Q1 FY27 |
|---|---|---|
| Wholesale | 6,839.00 | 6,804.00 |
| NIKE Direct | 4,514.00 | 4,142.00 |
| Operating signal | Current | Year-over-year context |
|---|---|---|
| Digital sales | −13% | NIKE Brand Digital |
| Owned-store sales | −5% | NIKE-owned stores |
| Converse revenue | $263M | −28% reported |
| Footwear revenue | $6,951M | Prior $7,410M |
| Apparel revenue | $3,384M | Prior $3,313M |
| Equipment revenue | $611M | Prior $630M |
The quarter's earnings bridge starts with $4.798 billion of gross profit and subtracts $3.910 billion of selling and administrative expense. That leaves $888 million of operating profit by arithmetic. Net interest income contributed $14 million and other net income contributed $19 million, bringing pretax income to $921 million. Tax expense of $209 million then leaves the reported $712 million of net income. The bridge separates operating performance from financing and other items, so a reader can see where the reported result was earned.
A year earlier the comparable operating-profit calculation was $927 million. The reduction in overhead softened the impact of lower gross profit, but it did not produce growth in operating dollars. Other income also compares favorably with the prior-year other expense. Pretax income was therefore almost unchanged even as operating profit declined. The higher effective tax rate then pushed net income lower. This is a reason to examine the full bridge rather than infer that a stable bottom line means underlying demand has stopped deteriorating.
The current effective tax rate was 22.7%, compared with 21.1% a year earlier, partly because of foreign tax audit settlements. Management expects a mid-twenties rate for fiscal 2027, subject to earnings mix and discrete items. Our forward EPS route uses the company's already-taxed adjusted guidance and therefore does not subtract tax again. The enterprise route uses operating earnings and an enterprise multiple, with net financial cash added once. Keeping those routes separate prevents double counting a balance-sheet benefit or charging the same financing cost twice.
Pace introduces another distinction between accounting profit and cash. Management expects approximately $1.0 billion of additional pretax charges through fiscal 2031, including about $0.3 billion in fiscal 2027, beyond roughly $0.3 billion recognized in fiscal 2026 under the earlier cost realignment plan. The program is expected to generate approximately $2.5 billion of cumulative savings through fiscal 2031, before these charges and any reinvestment. Cumulative savings are not an annual profit run rate. We do not capitalize the entire $2.5 billion as if it recurred every year or assume all savings become distributable cash.
| Step | $M |
|---|---|
| Gross profit | 4798 |
| SG&A | −3910 |
| Operating profit | 888 |
| Net interest income | 14 |
| Other income | 19 |
| Pretax | 921 |
| Tax | −209 |
| Net income | 712 |
| Measure | Value |
|---|---|
| Savings through FY31 | 2,500.00 |
| Additional charges through FY31 | 1,000.00 |
| Expected FY27 charges | 300.00 |
Our earnings-quality scorecard separates nine recurring questions: stock compensation, the GAAP-to-adjusted gap, below-the-line support, minority leakage, cash conversion, receivables, inventory, tax and the guidance record. The purpose is to identify what requires verification, not to compress unlike accounting issues into a reassuring average. NIKE's release supplies the current income statement and balance sheet, but it does not yet supply a fiscal first-quarter cash-flow statement. That missing statement remains a dated gap. We do not infer operating cash generation by subtracting two cash balances.
Receivables were $5.242 billion at August 31, compared with $4.962 billion a year earlier. Sales declined over the corresponding quarter. A simple ending-balance receivable-days proxy therefore rises. It is a warning to inspect collections and channel mix, not proof of improper recognition. The proxy uses ninety days and the quarter's revenue rather than a daily average of receivables. Seasonal shipment patterns and wholesale terms can affect it, so we show the definition and compare consistent periods.
Inventory was $7.846 billion, below the prior-year $8.114 billion, but cost of sales also declined. The ending-balance inventory-days proxy can therefore worsen despite a lower inventory balance. Management attributes the balance change primarily to product mix. Inventory quality depends on the mix, age and eventual selling price, not simply the total dollars. An inventory reduction achieved through healthy sell-through is more valuable than the same reduction achieved through heavy discounting that gives back the gross-margin recovery.
The annual cash record provides a useful discipline while the new quarter's statement is pending. Fiscal 2026 operating cash flow was $2.868 billion and capital spending was $684 million, leaving $2.184 billion of free cash flow by subtraction. Stock compensation was $715 million. A conservative owner-cash proxy deducts that compensation from free cash flow to recognize its economic cost, while acknowledging that the accounting expense and ultimate dilution are not identical. We use that proxy as one valuation input and disclose it explicitly; it is not an alternative cash-flow statement published by NIKE. The annual report separately records $385 million of total severance across its stated scope, including $142 million paid and $243 million remaining liability. The release's approximate prior-plan amount is not substituted for that broader annual total.
| Period | Q1 FY26 | Q1 FY27 |
|---|---|---|
| Receivable days | 38.10 | 42.07 |
| Inventory days | 107.76 | 110.08 |
| Period | Operating cash | Capital expenditure | Free cash flow |
|---|---|---|---|
| FY2024 | 7,429.00 | 812.00 | 6,617.00 |
| FY2025 | 3,698.00 | 430.00 | 3,268.00 |
| FY2026 | 2,868.00 | 684.00 | 2,184.00 |
The August balance sheet contains $6.903 billion of cash and equivalents and $1.465 billion of short-term investments. Together that is $8.368 billion of liquid financial assets. Against them stand $2.000 billion of current debt and $5.893 billion of long-term debt. The resulting net financial cash is only $475 million. Gross cash remains an important liquidity resource, but adding all of it to an equity valuation while ignoring the borrowings would materially overstate the cushion.
Operating lease obligations are shown separately. We exclude them from the simple net financial cash measure and use operating earnings consistently in the enterprise comparison. This is a disclosed convention, not a claim that stores or other leased facilities have no economic cost. A more elaborate lease-adjusted valuation would need to adjust both enterprise value and its earnings denominator together. We do not add lease debt to one side while leaving the other side on an incompatible basis.
Capital allocation is under pressure. Fiscal 2026 dividends of $2.407 billion exceeded the computed $2.184 billion of free cash flow. Buybacks were much smaller than in prior years, and the company had paused repurchases during fiscal 2026. The $18 billion authorization was extended without a fixed expiration date and without increasing its total capacity. Authorization is permission, not a commitment or an extra asset. A stronger buyback program would need support from cash generation and liquidity after dividends, investment and restructuring requirements.
The current quarter returned about $610 million through dividends. The declared quarterly dividend was $0.410 a share. Annualizing that payment gives $1.64, above the midpoint of fiscal 2027 adjusted EPS guidance. This comparison does not predict a dividend reduction: boards can draw on cash, earnings and cash flow differ, and the full year's payment has not been declared. It does show why investors should demand a credible funding bridge. A high dividend yield is less reassuring when the business also needs cash to finance its own repair.
| Measure | Value |
|---|---|
| Cash | 6,903.00 |
| Short investments | 1,465.00 |
| Current debt | 2,000.00 |
| Long debt | 5,893.00 |
| Net cash | 475.00 |
| Period | Dividends | Repurchases | Stock compensation |
|---|---|---|---|
| FY2024 | 2,169.00 | 4,250.00 | 804.00 |
| FY2025 | 2,300.00 | 2,985.00 | 709.00 |
| FY2026 | 2,407.00 | 146.00 | 715.00 |
| Balance-sheet item | Aug 31 2026 $M | Definition / caution |
|---|---|---|
| Cash + short investments | 8,368 | Liquid financial assets |
| Funded debt | 7,893 | Current 2,000 plus long-term 5,893 |
| Net financial cash | 475 | Excludes leases |
| Operating lease liabilities | 3,179 | Current 473 plus long-term 2,706 |
| Receivables | 5,242 | Ending balance |
| Inventory | 7,846 | Product mix and sellthrough matter |
| Total assets | 37,794 | Not all liquid |
| Equity | 15,220 | Book value is not fair value |
Our central value is $25 a share, within a deliberately broad $16 to $40 scenario range. Three routes support the judgment. The first applies a 22-times multiple to the $1.25 midpoint of fiscal 2027 adjusted EPS guidance, producing $27.50. Both the multiple and our willingness to look through restructuring are analyst assumptions. The calculation already grants the brand a meaningful recovery premium despite the expected revenue decline. Applying an even higher multiple requires stronger evidence that today's depressed earnings will recover rather than simply remain depressed.
The second route models $43.5 billion of future annual sales and a 5.5% operating margin, producing $2.3925 billion of operating profit. These are our normalized assumptions, not management guidance. Applying a 15-times enterprise multiple, adding $475 million of net financial cash and dividing by the 1,484.2 million diluted-share proxy produces approximately $24.50 a share. This route requires stabilization and operating execution. A sensitivity grid changes the margin and multiple so the reader can see how much of the conclusion rests on those choices.
The third route starts with $1.5 billion of annual owner cash, grows it 15% for the subsequent four years, discounts the five annual payments at 10%, and uses 2.5% perpetual growth thereafter. The result is about $20 a share. Owner cash means operating cash less capital spending and an economic stock-compensation allowance. Because this is a levered equity cash-flow route, we do not subtract borrowing or add cash a second time. The model embeds substantial improvement, yet produces the lowest of the three values. That is the principal reason we resist using an optimistic earnings multiple as the entire thesis.
At the saved reference, the market pays more than our base assumptions justify. The reverse test asks how much initial owner cash would be needed to support that price with the same growth, discount rate and terminal growth. It also asks what multiple investors are paying on the company's guidance midpoint. Those are transparent hurdle rates, not precise forecasts. Our bear, base and bull weights are 30%, 50% and 20%, respectively; their $16, $25 and $40 values produce $25.30 of probability-weighted value. High uncertainty leads us to seek a 20% margin below central value for a potential entry review, or $20, provided the operating thesis still holds.
$1.25 adjusted EPS midpoint ×22 = $27.50. Analyst multiple; no added cash.
$43,500M sales ×5.5% ×15 +$475M net cash, divided by 1,484.2M shares = $24.50. Analyst normalized assumptions.
$1,500M initial equity cash, 15% growth for 4 steps, 10% discount rate and 2.5% terminal growth = $20.03. No second debt or cash adjustment.
| Margin / multiple | 12× | 15× | 18× | 21× |
|---|---|---|---|---|
| 4.0% | $14.39 | $17.91 | $21.42 | $24.94 |
| 5.0% | $17.91 | $22.30 | $26.70 | $31.09 |
| 5.5% | $19.66 | $24.50 | $29.34 | $34.17 |
| 6.0% | $21.42 | $26.70 | $31.97 | $37.25 |
| 7.0% | $24.94 | $31.09 | $37.25 | $43.40 |
| Reverse test | Computed requirement | Interpretation |
|---|---|---|
| Forward P/E | 26.22× | Price / company EPS midpoint |
| EPS at22× | $1.49 | Above $1.25 guide midpoint |
| Initial owner cash | $2,455M | Same 15% growth / 10% discount / 2.5% terminal |
| EV / normalized operating profit | 20.14× | Versus our 15× route |
| Central value return | −23.7% | Value/price−1; not forecast return |
The saved analyst target consensus is $46.45, with a $44 median and a $30 to $75 range. The ratings snapshot contains 33 buy or strong-buy observations, 31 holds and 7 sells. These are provider aggregates with their own update schedules. They should not be mistaken for a set of fresh opinions incorporating every line of the October release. Our $25 central value is more cautious because the owner-cash route and near-term outlook leave less room for a smooth recovery than a simple brand multiple suggests.
The dated target-news record illustrates the issue. RBC Capital lowered its target to $40 on September 29. HSBC moved to $40 and Deutsche Bank to $37 on September 28, while Piper Sandler moved to $38 that day. These were already cautious revisions, but they preceded the current print. A target can be recent on the calendar and still be stale with respect to the information being analyzed. The table therefore retains firm, publication date and target rather than placing all observations under an undated Wall Street label.
The provider's fiscal 2027 EPS consensus is about $1.674, compared with management's newly stated adjusted range of $1.15 to $1.35. Revenue consensus is approximately $45.341 billion, whereas management describes a high-single-digit decline from fiscal 2026 revenue of $46.398 billion. Differences in estimate timing and adjusted definitions mean these are not perfectly interchangeable forecasts. Nevertheless, the gap is economically meaningful and makes subsequent estimate revisions a useful catalyst to watch. We do not manufacture a fully revised consensus immediately after publication.
The strongest challenge to our caution is that analysts may be valuing a later earnings base. If brand demand and direct sales stabilize sooner than our cash model assumes, a future EPS level near $2 could justify a much higher price at a twenty-times multiple. Our bull scenario makes that possibility explicit. The disagreement is about the probability, timing and cash cost of getting there. A favorable brand history is evidence of opportunity; it is not proof that the current reset will reach the optimistic outcome on schedule.
| Measure | Value |
|---|---|
| Buy / strong buy | 33.00 |
| Hold | 31.00 |
| Sell | 7.00 |
| Firm | Date | Target |
|---|---|---|
| RBC Capital | 2026-09-29 | $40.00 |
| HSBC | 2026-09-28 | $40.00 |
| Deutsche Bank | 2026-09-28 | $37.00 |
| Piper Sandler | 2026-09-28 | $38.00 |
| Oppenheimer | 2026-09-23 | $52.00 |
| Barclays | 2026-09-23 | $48.00 |
| Stifel Nicolaus | 2026-09-21 | $40.00 |
| UBS | 2026-09-17 | $42.00 |
| All listed target-news items precede October 1release. | ||
| Year ending May31 | Revenue $M | EPS | EPS analyst count |
|---|---|---|---|
| 2029 | 48,039.64 | 2.27 | 17 |
| 2028 | 46,816.60 | 2.07 | 28 |
| 2027 | 45,341.12 | 1.67 | 27 |
| Provider estimates may not yet reflect the new company guide. | |||
Management deserves credit for protecting marketing investment while cutting overhead and improving logistics economics. The quarter shows that those choices can support margin even when revenue contracts. The scorecard also records where execution is incomplete: direct sales continue to decline, Greater China is weak and Converse remains under pressure. We separate statements of strategic intent from measured outcomes. Describing a program as a transformation is not itself evidence that the program has created value.
Pace combines supply-chain modernization, a new campus in India, a realignment into three geographies and additional organizational streamlining. Its multi-year design creates both opportunity and execution risk. Savings may arrive later than cash charges, local labor requirements can affect timing, and reinvestment can absorb some of the gross benefits. The appropriate scorecard tracks realized recurring savings, cumulative cash costs and operating performance together. Counting savings while ignoring disrupted sales or necessary reinvestment would produce an incomplete assessment.
The leadership and governance record is also relevant. The annual report identifies PricewaterhouseCoopers as auditor, and shareholders ratified its appointment for fiscal 2027 at the completed September meeting. NIKE has Class A and Class B shares with different director-election rights; Class B is the listed security. The controlling influence associated with Class A ownership matters when assessing accountability, even though both classes participate economically in the business. These are disclosed structural considerations, not evidence of an unresolved contested proxy.
Our questions are concrete. How much of the expected savings is genuinely incremental after reinvestment? How will management distinguish healthier direct demand from clearance activity? What proportion of the inventory improvement represents units rather than mix or pricing? When will annual free cash flow again cover dividends with room for restructuring? Which metrics would cause management to change the pace or scope of the program? A useful answer should connect a number, a date and an accountable operating decision. The next packet will grade those answers against the signposts established here.
| Decision | Evidence | Assessment |
|---|---|---|
| Cost discipline | Overhead down 6%, demand creation up 5% | Constructive mix, sales still weak |
| Channel repair | Direct down 8%, wholesale down1% | Incomplete |
| Pace economics | $2.5Bcumulative savings before$1Bcharges / reinvestment | Conditional, multi-year |
| Cash allocation | FY26 dividends exceed $2.184B FCF | Funding test |
| Governance | Completed annual vote; PwC ratified | No current contested proxy established |
The highest operating risk is that the demand problem outlasts the cost reset. Footwear and direct sales are still declining, and an expense program cannot indefinitely substitute for products that customers want to buy at attractive prices. We rate this risk high in likelihood and high in impact relative to the valuation. The next is Greater China: the regional decline is severe enough that modest progress elsewhere can be overwhelmed. Currency-neutral disclosure helps distinguish translation from the underlying commercial challenge.
The next risk is cash timing. Restructuring charges, capital investment, dividends and working-capital needs can overlap before savings mature. The balance sheet provides liquidity, but the net financial cushion is considerably smaller than gross cash suggests. Supplier and geographic concentration also matter. The annual report discloses that several large contract manufacturers account for substantial footwear production, and trade policy can affect costs and cash recovery. These risks should influence the required margin of safety rather than be treated as boilerplate after selecting a price target.
The bull case is that performance products regain momentum, wholesale partners support a healthier marketplace and direct sales stabilize without another margin sacrifice. North America's growth and the gross-margin improvement support that argument. Successful execution could restore investor confidence before reported annual cash flow fully recovers, and the stock could rise well before our preferred entry level is reached. A cautious valuation can therefore be wrong through excessive conservatism as well as through bad arithmetic.
The bear case is that lower sales, continued China weakness and a persistent dividend funding gap force a longer reset. Our $16 scenario is not a liquidation estimate or a guaranteed floor; it represents weaker sustainable earnings and a lower multiple. The bull value is not a ceiling either. The broad distribution is why conviction is moderate and uncertainty high. The practical decision is to avoid paying for an uncomplicated recovery until the evidence or the price changes, while retaining clear conditions that would make us reconsider.
| Risk | Likelihood | Impact | Watch |
|---|---|---|---|
| Demand recovery delayed | High | High | Direct / footwear sales |
| Greater China weakness | High | High | Currency-neutral regional trend |
| Restructuring cash timing | Medium | High | Cash paid vs realized savings |
| Inventory quality | Medium | High | Mix/clearance/grossmargin |
| Concentration / trade | Medium | High | Manufacturing locations and tariffs |
| Recovery faster than model | Medium | High | Risk to our cautious call |
The next scheduled analytical checkpoint is the fiscal second quarter ending November 30, 2026. The release date is not assumed in this packet. We will compare direct-sales growth, Greater China revenue, gross margin and the EPS outlook against today's definitions. A subsequent first-quarter 10-Q, when filed, should also supply the cash-flow information absent from the earnings exhibit. That statement is an important evidence update even if it arrives without a dramatic share-price move.
Estimate revisions are another near-term catalyst. The saved Street forecasts do not yet match the company's newly released outlook, so changes in targets or consensus may reflect information already present in this packet rather than genuinely new operating news. We will distinguish a change in analyst opinion from a change in company fundamentals. The most useful positive revision would be supported by improved sales, margins or cash conversion; the least useful would simply apply a larger multiple to the same uncertain earnings base.
The multi-year Pace program creates a longer calendar. Fiscal 2027 charges are expected to be about $0.3 billion, with additional charges and savings extending through fiscal 2031. We will ask whether the company reports milestones in a way that allows cumulative commitments to be compared with cumulative delivery. A program that continually resets its baseline is difficult to grade. Until clearer milestones exist, the $2.5 billion savings estimate belongs in a conditional scenario rather than a mechanical addition to current earnings.
Price is also a catalyst, but only alongside the business. A move toward $20 would prompt an entry review under our present $25 central value and high-uncertainty margin requirement. It would not automatically create a BUY if guidance, liquidity or competitive position deteriorated at the same time. Conversely, better direct demand, less severe China declines and stronger cash coverage could raise fair value before the stock reaches that level. The signposts deliberately allow both routes to a different conclusion.
| Checkpoint | Date / period | Required evidence |
|---|---|---|
| First-quarter10-Q | When filed; date unconfirmed | Quarter cash flow and footnotes |
| Next operatingquarter | Ends November 30, 2026 | Direct/China/margin/guide |
| FY27 Pace cost | Fiscal yearendingMay31,2027 | About $300M expectedcharges |
| Pace cumulativeprogram | Through FY2031 | Savings before costs / reinvestment |
| Valuation entryreview | Each material filing | Around $20 only if thesis intact |
The dataset retains nine quarterly releases from Q1 fiscal 2025 through Q1 fiscal 2027, plus annual financial statements and three fiscal years of cash flows. Source URLs, saved files and exact table headings accompany the records. Annual and quarterly values are kept distinct. A fourth-quarter income statement can be obtained directly from its earnings release; a cash-flow figure derived from annual less nine-month statements is labeled as computed. Missing current-quarter cash-flow information remains missing rather than being filled with a provider estimate.
All amounts are in U.S. dollars unless a table states otherwise. Financial-statement tables use millions, while EPS, dividends and valuation outputs use dollars per share. Currency-neutral growth is the company's non-GAAP translation measure; it is not an alternative dollar revenue amount. Share-based compensation, restructuring charges and the tariff recovery are identified separately when disclosed. We do not invent a universal adjusted operating-profit series for periods in which the issuer did not publish that measure.
Derived values are calculated from the saved dataset: margins, growth, operating profit, net financial cash, working-capital days, free cash flow, owner-cash proxies, valuation routes and scenario weighting. Ending-balance day measures use ninety days and are comparisons rather than precise collection or inventory-turn schedules. The diluted weighted-average share count is a valuation proxy with a clearly stated limitation. Assumptions such as multiples, discount rates, growth rates, normalized revenue and scenario probabilities are ours and can be varied in the sensitivity analysis.
This is a new-period analysis rather than a rewrite of the prior Q4 fiscal 2026 videos. Their titles and identities are retained in the source review, and the current thesis focuses on sales recovery, restructuring economics and cash funding. No prior structured packet signposts for this exact comparison were established in the available packet record, so we do not fabricate a graded track record. Future updates should preserve today's assumptions and report which tests improved, which failed and why the valuation changed.
| Quarter | Revenue $M | Operating $M | Net income $M | Diluted EPS |
|---|---|---|---|---|
| Q1 FY2025 | 11,589.00 | 1,209.00 | 1,051.00 | 0.70 |
| Q2 FY2025 | 12,354.00 | 1,384.00 | 1,163.00 | 0.78 |
| Q3 FY2025 | 11,269.00 | 788.00 | 794.00 | 0.54 |
| Q4 FY2025 | 11,097.00 | 321.00 | 211.00 | 0.14 |
| Q1 FY2026 | 11,720.00 | 927.00 | 727.00 | 0.49 |
| Q2 FY2026 | 12,427.00 | 1,006.00 | 792.00 | 0.53 |
| Q3 FY2026 | 11,279.00 | 553.00 | 520.00 | 0.35 |
| Q4 FY2026 | 10,972.00 | 1,311.00 | 1,069.00 | 0.72 |
| Q1 FY2027 | 11,213.00 | 888.00 | 712.00 | 0.48 |
| Fiscal year | OCF $M | Capex $M | FCF $M | SBC $M | Dividends $M |
|---|---|---|---|---|---|
| FY2024 | 7,429 | 812 | 6,617 | 804 | 2,169 |
| FY2025 | 3,698 | 430 | 3,268 | 709 | 2,300 |
| FY2026 | 2,868 | 684 | 2,184 | 715 | 2,407 |
| Structure | Verified context |
|---|---|
| Listing | NYSE: NKE Class B common stock; no ADS |
| Voting | Class A and Class B have different director-election rights |
| Auditor | PricewaterhouseCoopers; since 1974 |
| Employees | Approximately 73,000 at May 31, 2026 |
| Customer concentration | No customer 10%+ of FY26 revenue |
| Manufacturing | Four footwear manufacturers: about 60% of FY26 production |
| Repurchases | $18B authorization extended without fixed expiration; paused FY26 |